Sergio Scaccabarozzi
- Hepatology top 2%
- Epidemiology top 10%
- Rheumatology
- Infectious Diseases
- Immunology
- Co-authors
- Antonella MandasPeter Van EykenDomenico CriscuoloG. RealdiL. CarusoA. RuolMaria Eliana LaiValeer Desmet
- Topics
- Hepatitis C virus research (5 papers)Diabetes and associated disorders (2 papers)Liver Disease Diagnosis and Treatment (2 papers)
- Cited by
- HepatologyEpidemiologyRheumatology
- Journals
- New England Journal of MedicineSHILAP Revista de lepidopterologíaHepatology
- Partner nations
- ItalySwitzerlandBelgium
In The Last Decade
Sergio Scaccabarozzi
10 papers receiving 398 citations
Peers
Comparison fields: 5 of 42
- Hepatology 334
- Epidemiology 326
- Rheumatology 57
- Infectious Diseases 44
- Immunology 24
Countries citing papers authored by Sergio Scaccabarozzi
This map shows the geographic impact of Sergio Scaccabarozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Scaccabarozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Scaccabarozzi more than expected).
Fields of papers citing papers by Sergio Scaccabarozzi
This network shows the impact of papers produced by Sergio Scaccabarozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Scaccabarozzi. The network helps show where Sergio Scaccabarozzi may publish in the future.
Co-authorship network of co-authors of Sergio Scaccabarozzi
This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Scaccabarozzi. A scholar is included among the top collaborators of Sergio Scaccabarozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Scaccabarozzi. Sergio Scaccabarozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection. | 15 |
| 3 | 42 | |
| 4 | 221 | |
| 5 | 64 | |
| 6 | [Treatment of cryptogenic chronic liver diseases with recombinant alpha-2a interferon. Preliminary results of a randomized controlled clinical trial]. | 3 |
| 7 | 41 | |
| 8 | 1 | |
| 9 | 25 | |
| 10 | 5 |
About Sergio Scaccabarozzi
Sergio Scaccabarozzi is a scholar working on Hepatology, Virology and Critical Care and Intensive Care Medicine, having authored 10 papers that have together received 419 indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Diabetes and associated disorders (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (334 citations), Epidemiology (326 citations) and Rheumatology (57 citations). Sergio Scaccabarozzi has collaborated with scholars based in Italy, Switzerland and Belgium. Frequent co-authors include Antonella Mandas, Peter Van Eyken, Domenico Criscuolo, G. Realdi, L. Caruso, A. Ruol, Maria Eliana Lai, Valeer Desmet, Yukio Gibo and Patrizia Farci. Their work appears in journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.